Latest Articles
June 20, 2024
From Vision to Reality: Best Practices for Building High-Risk Breast Programs
A high-risk breast program is designed to identify patients with an elevated risk of developing breast cancer and then offering genetic counseling, genetic testing, additional…
Breast Cancer
Breast Cancer Awareness
Genetic Testing
OBGYN
June 11, 2024
A Journey through the Undiagnosed Disease Program: An Interview with Ellen Macnamara, MS, CGC
Patients with a rare disease and going through a diagnostic odyssey wait for years without answers. Ellen Macnamara, ScM, CGC, explains how these cases journey…
Genetic Testing
TRUE
Whole Exome Sequencing
May 30, 2024
Research Recap: Determining Gene-Disease Validity in POT1 Tumor Predisposition
Ambry set out to determine the prevalence of cancer types in individuals with POT1 pathogenic variants (PVs) undergoing multigene panel testing (MGPT) for a broad…
Genetic Testing
Multigene Panel Testing
May 2, 2024
Gene-Disease Validity: Developing and Applying a Rigorous Framework in a Diagnostic Laboratory Setting
The Patient for Life Program helps provide accurate, up-to-date and accessible genetic testing options.
Genetic Testing Accuracy
Tag
VUS
Whole Exome Sequencing
May 1, 2024
Putting Patients First: The Ambry CARE Program®’s Commitment to Patient Experience
Heather Fecteau explains how since the launch of the Ambry CARE Program® in 2019, Ambry has also consistently helped to improve the delivery of genetic…
BRCA1 & 2
Breast Cancer
Genetic Counselors
Genetic Testing
Screening
April 30, 2024
Advancing Equity: TriHealth’s Experience Leveraging CARE to Standardize Cancer Risk Assessment
Chelsea Menke, MS, CGC, discusses addressing health inequalities at TriHealth gynecology clinic with the Ambry CARE Program.
Genetic Discrimination
Genetic Testing
Genetic Testing Accuracy
OBGYN
![overlay-bottom[1]](https://ambrygen.com/wp-content/uploads/2026/02/overlay-bottom1.svg)